分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Clinical comparison and functional study of the L703P: a recurrent mutation in human SCN4A that causes sodium channel myotonia

Qing Ke, Youcheng Zhao, Yuezhou Li, Jia Ye, Siyang Tang, Fangping He, Fang Ji, Xuejiao Dai, Jie Ni, Yi Li, Robert C. Griggs, Xiaoyang Cheng

Journal:NEUROMUSCULAR DISORDERS

IF:3.54

DOI:10.1016/j.nmd.2022.08.004

PMID:36050252

Published:2022-08-17

research field:高分子科学心血管器械生物医学工程材料科学组织工程

Abstract

The non-dystrophic myotonias are inherited skeletal muscle disorders characterized by skeletal muscle stiffness after voluntary contraction, without muscle atrophy. Based on their clinical features, non-dystrophic myotonias are classified into myotonia congenita, paramyotonia congenita, and sodium channel myotonia. Using whole-exome next-generation sequencing, we identified a L703P mutation (c.2108T>C, p.L703P) in SCN4A in a Chinese family diagnosed with non-dystrophic myotonias. The clinical findings of patients in this family included muscle stiffness and hypertrophy. The biophysical properties of wildtype and mutant channels were investigated using whole-cell patch clamp. L703P causes both gain-of-function and loss-of-function changes in Nav1.4 properties, including decreased current density, impaired recovery, enhanced activation and slow inactivation. Our study demonstrates that L703P is a pathogenic variant for myotonia, and provides additional electrophysiological information for understanding the pathogenic mechanism of SCN4A -associated channelopathies.

本文使用的Yeasen产品

购物车
客服
转染试用